Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Change in Receivables (2016 - 2024)

Historic Change in Receivables for Prothena Corp Public (PRTA) over the last 12 years, with Q1 2024 value amounting to -$5.2 million.

  • Prothena Corp Public's Change in Receivables changed N/A to -$5.2 million in Q1 2024 from the same period last year, while for Dec 2024 it was -$5.2 million, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of -$5.2 million for FY2024, which is 20000.0% down from last year.
  • Latest data reveals that Prothena Corp Public reported Change in Receivables of -$5.2 million as of Q1 2024.
  • Prothena Corp Public's 5-year Change in Receivables high stood at $4.6 million for Q3 2023, and its period low was -$5.2 million during Q1 2024.
  • Moreover, its 4-year median value for Change in Receivables was -$7000.0 (2020), whereas its average is -$6181.8.
  • Within the past 5 years, the most significant YoY rise in Prothena Corp Public's Change in Receivables was 202000.0% (2020), while the steepest drop was 158571.43% (2020).
  • Over the past 4 years, Prothena Corp Public's Change in Receivables (Quarter) stood at -$7000.0 in 2020, then plummeted by 1028.57% to -$79000.0 in 2021, then surged by 5967.09% to $4.6 million in 2023, then tumbled by 211.31% to -$5.2 million in 2024.
  • Its last three reported values are -$5.2 million in Q1 2024, $4.6 million for Q3 2023, and $524000.0 during Q2 2023.